+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Encephalopathy Market by Treatment Type (Devices, Pharmaceuticals, Surgical Procedures), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Patient Age Group - Global Forecast 2025-2030- Product Image
Encephalopathy Market by Treatment Type (Devices, Pharmaceuticals, Surgical Procedures), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Patient Age Group - Global Forecast 2025-2030- Product Image
Sale

Encephalopathy Market by Treatment Type (Devices, Pharmaceuticals, Surgical Procedures), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Patient Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015276
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The encephalopathy market is undergoing significant transformation as healthcare providers prioritize early intervention, advanced diagnostics, and multidisciplinary patient management. Industry leaders are increasingly focusing on innovative solutions and adaptive strategies to address complex care needs and maintain a competitive edge.

Market Snapshot: Encephalopathy Market Size and Growth

The Encephalopathy Market expanded from USD 196.85 million in 2024 to USD 209.06 million in 2025 and is projected to reach USD 281.70 million by 2030, sustaining a compound annual growth rate (CAGR) of 6.15%. This growth reflects substantial advancements in diagnostics, device technologies, and therapeutic protocols, as well as evolving stakeholder priorities in patient outcomes and cost containment.

Scope & Segmentation of the Encephalopathy Market

  • Treatment Types: Market offerings span blood purification systems, hemodialysis devices, liver support devices, pharmaceuticals such as lactulose and rifaximin, and key surgical procedures like liver transplantation and shunt surgeries.
  • Distribution Channels: Critical therapies are delivered through hospital pharmacies, online pharmacies, and retail pharmacies.
  • End Users: Management settings include home care, hospitals, and specialty clinics, each playing a role in acute and chronic applications.
  • Patient Age Groups: Therapeutic protocols sensitive to adult, geriatric, and pediatric populations address diverse comorbidities and developmental needs.
  • Geographical Coverage: Regional analysis encompasses the Americas, Europe, Middle East & Africa, and Asia-Pacific territories, with key country-level focus areas identified for tailored strategies.
  • Companies Profiled: The report examines major organizations such as Salix Pharmaceuticals, Abbott Laboratories, Fresenius Kabi, Sandoz International, Teva, Cipla, Lupin, Apotex, Sun Pharmaceutical Industries, and B. Braun Melsungen.

Key Takeaways for Senior Decision-Makers

  • Precision diagnostics and digital therapeutics are driving substantial improvements in early detection and treatment specificity, reducing the burden of adverse neurological outcomes.
  • Integrated, patient-centric care models are becoming standard, requiring closer collaboration among neurologists, hepatologists, dietitians, and rehabilitation specialists for optimal results.
  • Telemedicine platforms and remote monitoring tools are reshaping patient management by enabling real-time data analysis, adherence support, and proactive intervention strategies.
  • Healthcare infrastructure and regulatory requirements vary considerably across key regions, necessitating adaptable market entry, supply chain, and pricing strategies.
  • A wave of mergers, acquisitions, and strategic partnerships is consolidating the competitive landscape and accelerating innovation in device and pharmaceutical development.
  • Personalized nutrition, cognitive rehabilitation, and enhanced caregiver support are increasingly recognized as necessary adjuncts to pharmacological and procedural interventions.

Tariff Impact: Navigating Supply Chain and Cost Challenges

The implementation of United States tariffs in 2025 has placed added pressure on supply chains involved in encephalopathy care. Increased import duties on devices and active pharmaceutical ingredients have prompted manufacturers and providers to reassess sourcing, operational costs, and contract structures. In response, some organizations are investing in regional production and forming strategic partnerships to maintain supply continuity and reduce cost volatility.

Methodology & Data Sources: Ensuring Reliable Encephalopathy Market Insights

A hybrid research approach included interviews with clinicians, engineers, and supply chain experts, together with advisory board feedback from patient advocacy organizations. Secondary sources comprised peer-reviewed journals, regulatory documents, and industry reports. Data triangulation and quality assurance processes validated findings and ensured accuracy.

Why This Report Matters for Industry Leaders

  • Enables robust evaluation of emerging diagnostic and therapeutic solutions to optimize capital allocation and R&D priorities.
  • Delivers segmentation and regional insights essential for customizing go-to-market strategies, partnerships, and resource deployment.
  • Supports informed pricing, sourcing, and negotiation decisions in a dynamic global trade and regulatory environment.

Conclusion

The encephalopathy market is characterized by continual clinical innovation and shifting regional landscapes. Strategic collaboration and adaptive decision-making remain vital for sustainable growth and improved patient care outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven imaging analytics to improve early encephalopathy diagnosis and monitoring
5.2. Adoption of wearable biosensor platforms for continuous encephalopathy symptom monitoring in outpatient settings
5.3. Development of novel small molecule inhibitors targeting neuroinflammation pathways in hepatic encephalopathy patients
5.4. Expansion of telemedicine-based neurological assessments to manage remote encephalopathy treatment programs in rural areas
5.5. Regulatory approval of next-generation monoclonal antibodies for autoimmune encephalopathy management across EU and US markets
5.6. Implementation of precision medicine strategies using pharmacogenomic profiling to optimize encephalopathy drug regimens
5.7. Rising investment in digital therapeutics combining cognitive rehabilitation with brain stimulation for encephalopathy recovery
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Encephalopathy Market, by Treatment Type
8.1. Introduction
8.2. Devices
8.2.1. Blood Purification Systems
8.2.2. Hemodialysis Devices
8.2.3. Liver Support Devices
8.3. Pharmaceuticals
8.3.1. Lactulose
8.3.2. Rifaximin
8.4. Surgical Procedures
8.4.1. Liver Transplantation
8.4.2. Shunt Surgeries
9. Encephalopathy Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Encephalopathy Market, by End User
10.1. Introduction
10.2. Home Care Settings
10.3. Hospitals
10.4. Specialty Clinics
11. Encephalopathy Market, by Patient Age Group
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Americas Encephalopathy Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Encephalopathy Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Encephalopathy Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Salix Pharmaceuticals, Inc.
15.3.2. Abbott Laboratories
15.3.3. Fresenius Kabi AG
15.3.4. Sandoz International GmbH
15.3.5. Teva Pharmaceutical Industries Ltd.
15.3.6. Cipla Limited
15.3.7. Lupin Limited
15.3.8. Apotex Inc.
15.3.9. Sun Pharmaceutical Industries Ltd.
15.3.10. B. Braun Melsungen AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ENCEPHALOPATHY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ENCEPHALOPATHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ENCEPHALOPATHY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ENCEPHALOPATHY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ENCEPHALOPATHY MARKET: RESEARCHAI
FIGURE 24. ENCEPHALOPATHY MARKET: RESEARCHSTATISTICS
FIGURE 25. ENCEPHALOPATHY MARKET: RESEARCHCONTACTS
FIGURE 26. ENCEPHALOPATHY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ENCEPHALOPATHY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENCEPHALOPATHY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ENCEPHALOPATHY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY BLOOD PURIFICATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY BLOOD PURIFICATION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HEMODIALYSIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HEMODIALYSIS DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY LIVER SUPPORT DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY LIVER SUPPORT DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY LACTULOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY LACTULOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY RIFAXIMIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY RIFAXIMIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SHUNT SURGERIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SHUNT SURGERIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 96. CANADA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 97. CANADA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 98. CANADA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 99. CANADA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 100. CANADA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 101. CANADA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. CANADA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. CANADA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. CANADA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. CANADA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 106. CANADA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 107. MEXICO ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 113. MEXICO ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 114. MEXICO ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. MEXICO ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 120. MEXICO ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 179. GERMANY ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 182. GERMANY ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 183. GERMANY ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 184. GERMANY ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 185. GERMANY ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 186. GERMANY ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 187. GERMANY ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. GERMANY ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. GERMANY ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. GERMANY ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. GERMANY ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 192. GERMANY ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 193. FRANCE ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 196. FRANCE ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 197. FRANCE ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 198. FRANCE ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 199. FRANCE ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 200. FRANCE ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 201. FRANCE ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. FRANCE ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. FRANCE ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. FRANCE ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. FRANCE ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 206. FRANCE ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 221. ITALY ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 222. ITALY ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 223. ITALY ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 224. ITALY ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 225. ITALY ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 226. ITALY ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 227. ITALY ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 228. ITALY ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 229. ITALY ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. ITALY ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. ITALY ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ITALY ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. ITALY ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 234. ITALY ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 235. SPAIN ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 238. SPAIN ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 239. SPAIN ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 240. SPAIN ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 241. SPAIN ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 242. SPAIN ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 243. SPAIN ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SPAIN ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SPAIN ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. SPAIN ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SPAIN ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 248. SPAIN ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 291. DENMARK ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 292. DENMARK ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 293. DENMARK ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 294. DENMARK ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 295. DENMARK ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 296. DENMARK ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 297. DENMARK ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 298. DENMARK ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 299. DENMARK ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. DENMARK ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. DENMARK ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. DENMARK ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. DENMARK ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 304. DENMARK ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 319. QATAR ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 320. QATAR ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 321. QATAR ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 322. QATAR ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 323. QATAR ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 324. QATAR ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 325. QATAR ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 326. QATAR ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 327. QATAR ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. QATAR ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. QATAR ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. QATAR ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. QATAR ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 332. QATAR ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 333. FINLAND ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 334. FINLAND ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 335. FINLAND ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 336. FINLAND ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 337. FINLAND ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 338. FINLAND ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 339. FINLAND ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 340. FINLAND ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 341. FINLAND ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. FINLAND ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. FINLAND ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. FINLAND ENCEPHALOPATHY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. FINLAND ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 346. FINLAND ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 347. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 348. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 349. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 350. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 351. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 352. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 353. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 354. SWEDEN ENCEP

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Encephalopathy market report include:
  • Salix Pharmaceuticals, Inc.
  • Abbott Laboratories
  • Fresenius Kabi AG
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Lupin Limited
  • Apotex Inc.
  • Sun Pharmaceutical Industries Ltd.
  • B. Braun Melsungen AG

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 209.06 Million
Forecasted Market Value ( USD ) by 2030 $ 281.7 Million
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Overt Hepatic Encephalopathy Market - Product Image

Overt Hepatic Encephalopathy Market

  • Report
  • 250 Pages
  • Global
From
Hepatic Encephalopathy (HE) Treatment - Global Strategic Business Report - Product Image

Hepatic Encephalopathy (HE) Treatment - Global Strategic Business Report

  • Report
  • 283 Pages
  • Global
From
Hepatic Encephalopathy Epidemiology Forecast 2025-2034 - Product Image

Hepatic Encephalopathy Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Hepatic Encephalopathy Market Report 2025 - Product Image

Hepatic Encephalopathy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Encephalopathy- Pipeline Insight, 2025 - Product Image

Encephalopathy- Pipeline Insight, 2025

  • Clinical Trials
  • 210 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.